Last $89.38 USD
Change Today -0.07 / -0.08%
Volume 920.2K
BMRN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for biomarin pharmaceutical inc (BMRN)

Although debt as a percent of total capital increased at BioMarin Pharmaceutical Inc. over the last fiscal year to 32.83%, it is still in-line with the Biotechnology industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 75.49 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 118.00 days.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents88.146.3180.5568.8
Short-Term Investments186.0148.8267.3215.9
TOTAL CASH AND SHORT TERM INVESTMENTS274.1195.1447.8784.7
Accounts Receivable86.6104.8109.1117.8
Other Receivables7.3------
TOTAL RECEIVABLES93.9104.8109.1117.8
Inventory109.7130.1128.7162.6
Prepaid Expenses8.5------
Deferred Tax Assets, Current16.721.132.430.6
Other Current Assets1.518.625.541.7
TOTAL CURRENT ASSETS504.3469.8743.41,137.4
Gross Property Plant and Equipment306.9384.7433.6504.4
Accumulated Depreciation-85.1-115.7-149.1-185.0
NET PROPERTY PLANT AND EQUIPMENT221.9269.0284.5319.3
Goodwill53.451.551.554.3
Long-Term Investments129.394.9120.0281.5
Deferred Tax Assets, Long Term236.0224.7189.3150.4
Deferred Charges, Long Term----3.715.4
Other Intangibles103.6180.3163.0163.1
Other Long-Term Assets14.215.512.9127.8
TOTAL ASSETS1,262.61,305.71,568.32,249.2
    
LIABILITIES & EQUITY    
Accounts Payable5.012.224.036.9
Accrued Expenses66.374.3108.4128.5
Current Portion of Long-Term Debt/Capital Lease----23.4--
Current Income Taxes Payable0.5------
Other Current Liabilities, Total12.17.614.717.9
TOTAL CURRENT LIABILITIES83.894.1170.4183.3
Long-Term Debt377.5348.3324.9655.6
Deferred Tax Liability Non-Current36.537.2----
Other Non-Current Liabilities47.553.157.369.3
TOTAL LIABILITIES545.4532.7552.6908.2
Common Stock0.10.10.10.1
Additional Paid in Capital1,090.21,197.11,561.92,059.1
Retained Earnings-371.3-425.1-539.4-715.8
Comprehensive Income and Other-1.81.0-6.8-2.4
TOTAL COMMON EQUITY717.3773.01,015.81,341.0
TOTAL EQUITY717.3773.01,015.81,341.0
TOTAL LIABILITIES AND EQUITY1,262.61,305.71,568.32,249.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $89.38 USD -0.07

BMRN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.112.90 CHF +0.60
Alkermes PLC $55.01 USD +0.84
Jazz Pharmaceuticals PLC $176.65 USD +6.22
Spectrum Pharmaceuticals Inc $7.38 USD +0.02
Vertex Pharmaceuticals Inc $115.39 USD +1.20
View Industry Companies
 

Industry Analysis

BMRN

Industry Average

Valuation BMRN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 19.7x
Price/Book 8.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.